AndrostadienesAdministration, InhalationBronchodilator AgentsAnti-Asthmatic AgentsAlbuterolPropionatesPregnenedionesAnti-Inflammatory AgentsBudesonideBeclomethasoneAdministration, TopicalAsthmaPeak Expiratory Flow RateDouble-Blind MethodForced Expiratory VolumeNebulizers and VaporizersGlucocorticoidsDrug CombinationsAnti-Allergic AgentsNasal SpraysHydrocortisoneCross-Over StudiesFluocinolone AcetonideMetered Dose InhalersCarbocysteinePulmonary Disease, Chronic ObstructivePowdersPregnadienediolsAdrenal Cortex HormonesEmollientsAerosolsBronchial HyperreactivityTreatment OutcomeAdrenergic beta-2 Receptor AgonistsAcetatesDrug Therapy, CombinationDrug Administration ScheduleScopolamine DerivativesBronchoconstrictor AgentsEthanolaminesRespiratory Function TestsDose-Response Relationship, DrugRhinitis, Allergic, SeasonalAdrenal GlandsLeukotriene AntagonistsAdministration, IntranasalQuinolinesSputumBiological AvailabilityBronchial Provocation TestsVital CapacityAdrenergic beta-AgonistsNasal Lavage FluidLungRhinitis, Allergic, PerennialChlorobenzenesBronchiTestosterone PropionateGrowthDermatologic AgentsNasal MucosaEosinophilsMethacholine ChloridePrednisoloneTriamcinolone AcetonideAirway ResistanceSpirometryFatty Acids, VolatileDrug Delivery SystemsBenzyl AlcoholsLung Diseases, ObstructiveAnalysis of VarianceQuality of LifeClobetasolInhalation SpacersRumenDermatitis, AtopicCost-Benefit AnalysisTime FactorsButyratesFermentationRandomized Controlled Trials as TopicDry Powder InhalersMalonatesArylsulfonatesCharcoalSulfonium CompoundsMonensin